Positive Results Announced from Phase III IMscin001 Study Evaluating Subcutaneous Formulation of Tecentriq® with ENHANZE® in Advanced Non-Small Cell Lung Cancer

 Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Roche’s Phase III IMscin001 study evaluating a subcutaneous…

Avillion announces publication of positive full results from MANDALA Phase III trial of AstraZeneca’s PT027 in asthma patients in the New England Journal of Medicine

First time an albuterol/budesonide fixed-dose combination rescue medication used as needed has been shown to reduce…

Toku Eyes, Developer of an AI Platform That Accurately Identifies Risk of Heart Attack Using an Eye Image, Expands to The US

 Toku Eyes, the New Zealand-based developer of a multi-modal artificial intelligence platform for instant healthcare diagnostics, today…

Cross-border system launched to unify digital health standards in the Nordics

A world-first programme to unify digital health standards across multiple countries, is being launched by the…

Animal Pregnancy Test Kit Market Size to Grow by USD 98.33 Mn| 40% of the growth to originate from North America| Technavio

– The Animal Pregnancy Test Kit Market value is expected to grow by USD 98.33 million from 2021 to 2026,…

Beijing links health codes to transport cards and more briefs

A new ticketing system in China’s capital Beijing has linked commuters’ COVID-19 health codes to their…

Health informatics curriculum, national data integration and EMRAM adoption on agenda for Indonesia

Indonesia’s healthcare sector has a number of tasks to complete in its digital transformation quest, according…

Indonesia’s challenges in digital transformation: IHC president

Dr Fathema Djan Rachmat, president director of the Indonesia Healthcare Corporation (IHC), said Indonesia still faces…

Greenfire Bio to update progress on Phase 1 Clinical Trial for SIK2/SIK3 inhibitor, GRN-300, in ovarian cancer at the ASCO Annual Meeting 2022

 Greenfire Bio, LLC announced today that its subsidiary, Green3Bio, and its collaborators at MD Anderson Cancer…

BIO KOREA, Asia’s Biggest Bio-Health Convention, to Open in May 2022

Initiated in 2006, BIO KOREA is the biggest bio-health convention in Asia that is dedicated to promoting the…